-
Dr. Huiqiang Huang: Combining PD-1 Monoclonal Antibody and HDAC Inhibitor with Conventional P-Gemox Significantly Improves the Treatment Outcome for NK/T Cell Lymphoma
Editor’s Note: From June 17th to 23rd, 2023, the 17th International Conference on Malignant Lymphoma (ICML) was held grandly in Lugano, Switzerland. As the world’s largest conference on malignant lymphoma,…
-
Strategy First! UCLI-ICML Joint Session Lays Foundation for Collaboration
Editor’s note: From June 13-17, 2023, the 17th International Conference on Malignant Lymphoma (ICML) was held in Lugano, Switzerland. As the largest international conference on malignant lymphoma, the event gathered…
-
The Safety of Anticoagulation Therapy in Liver Cirrhosis Portal Vein Thrombosis and Its Impact on Hospital Outcomes.
“The Hepatology Digest -Liver Vascular Disease Column” is an academic section jointly initiated by Dr. Xingshun Qi of the Department of Gastroenterology, Northern Theater General Hospital, at the invitation of the Hepatology Digest editorial team. It regularly collects and discusses the latest research in the field of liver vascular diseases. Every two weeks, on Wednesdays,…
-
The Treatment and Clinical Cure of Childhood Hepatitis B
China is a country with a high incidence of hepatitis B, and mother-to-child transmission is an important route for children in China to contract the hepatitis B virus (HBV). Although chronic HBV infection in childhood rarely progresses to active hepatitis, there is still a risk of developing cirrhosis and liver cancer. Therefore, understanding the epidemiological…
-
Strategies to Optimize CAR-T Cell Therapy in Hematological Malignancies: Chinese Experience
🩸 Advancements in Hematological Malignancies: Professor Xiaojun Huang’s Insights on CAR-T Cell Therapy In the landscape of oncology, hematological malignancies cast a formidable shadow, spanning leukemia, lymphoma, and multiple myeloma. Yet, amidst these intricate conditions, a beacon of hope emerges through the transformative strides of CAR-T cell therapy. This groundbreaking approach stands as a promising…
-
Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic
🩸 Resilience Amidst Crisis: Prof. Xiaojun Huang’s Pioneering Insights on HSCT during COVID-19 In a world disrupted by the SARS-CoV-2 pandemic, the adaptability and innovation of medical practices became imperative. An illuminating study, recently unveiled in Transplantation and Cellular Therapy’s February 2023 publication, sheds light on a beacon of hope amidst this chaos. Titled “Hematopoietic…
-
Professor Xiaojun Huang ‘s Team Reveals New Mechanism of Injury to Bone Marrow Endothelial Progenitor Cells and Proposes Targeted Repair Strategies
🩸 Professor Xiaojun Huang and Team: Illuminating Hope in Blood Health Meet the unsung heroes—Professor Xiaojun Huang and their dedicated team—who’ve ventured into the labyrinth of blood health, uncovering a profound truth within our marrow’s tapestry. They’ve unraveled a poignant narrative—a disruption in glycolysis, a hidden force causing turmoil for endothelial progenitor cells (EPCs). This…
-
CDL (co-management of diabetes-liver diseases strategy,) Literature Monthly Review – November 2023, Issue 10
Diabetes and liver diseases are common chronic conditions in China, and they interact in terms of pathogenesis, clinical manifestations, and therapeutic targets, often posing mutual risk factors. Co-management of these conditions is beneficial for reducing the burden of disease. To support the development of diabetes and liver disease co-management in China, this publication Hepatology Digest,…
Connecting Medical Expertise through Media